6505-01-361-5235 ( NDC00108-4904-20 , STELAZINE , NDC00781-1032-01 , STELAZINE TABLETS , NDC00378-2402-01 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-361-5235 6505 013615235 TRIFLUOPERAZINE HYDROCHLORIDE TA 3421
NSN Features
MRC Parameter Characteristics
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY TRIFLUOPERAZINE HYDROCHLORIDE TABLETS US 100S BT
CQCT PRIMARY CONTAINER TYPE BOTTLE
CRLK PRIMARY CONTAINER CONTENT QUANTITY 100.000 TABLETS
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 2.000 MILLIGRAMS TRIFLUOPERAZINE EQUIVALENT
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC00108-4904-20 93544 A 2 3 4 KX
STELAZINE 93544 A 1 5 4 KX
NDC00781-1032-01 71115 A 2 5 4 ZZ
STELAZINE TABLETS 93544 A 1 5 4 KX
NDC00378-2402-01 60895 A 2 5 4 ZZ
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC00108-4904-20 93544 GLAXOSMITHKLINE HOLDINGS AMERICA A A
STELAZINE 93544 GLAXOSMITHKLINE HOLDINGS AMERICA A A
NDC00781-1032-01 71115 BRISTOL-MYERS CO A A
STELAZINE TABLETS 93544 GLAXOSMITHKLINE HOLDINGS AMERICA A A
NDC00378-2402-01 60895 MYLAN PHARMACEUTICALS INC A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 07/18/1 P 3004909135 3421
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DS I K U/I CONTAINS 100 TT
DN 9B----- N K U/I CONTAINS 100 TT
DF ------- F K U/I CONTAINS 100 TT
VA V K U/I CONTAINS 100 TT
DA C2201X- A K U/I CONTAINS 100 TT
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DN SMS L 1 BT M U 9B----- N
DF SMS L 1 BT M U ------- F
VA I 1 BT M U V
DS SMS L 1 BT M U D
DA SMS L 1 BT M U C2201X- A
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC